Joan J. Ryoo

1.1k total citations · 1 hit paper
19 papers, 872 citations indexed

About

Joan J. Ryoo is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joan J. Ryoo has authored 19 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joan J. Ryoo's work include Global Cancer Incidence and Screening (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Joan J. Ryoo is often cited by papers focused on Global Cancer Incidence and Screening (4 papers), Palliative Care and End-of-Life Issues (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Joan J. Ryoo collaborates with scholars based in United States and Australia. Joan J. Ryoo's co-authors include Kenneth C. Anderson, Teru Hideshima, Andrea Freeman, Faith E. Davies, Laurence Catley, Rebecca L. Rich, Edie Weller, Deborah Doss, Jerome B. Zeldis and Richard LeBlanc and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Joan J. Ryoo

18 papers receiving 837 citations

Hit Papers

Immunomodulatory drug CC-5013 overcomes drug resistance a... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
    2002 630 citations Paul G. Richardson, Robert Schlossman et al. Blood profile →

Peers

Joan J. Ryoo
Stephen P. Kahanic United States
Dorothy Romanus United States
Jianming He United States
Lucia Pantani Italy
Christopher Enny United States
Stefanie Hieke Germany
Jason Valent United States
A.K. Kakkar United Kingdom
Ming‐Chung Kuo Taiwan
Claus Werenberg Marcher Denmark
Stephen P. Kahanic United States
Joan J. Ryoo
Citations per year, relative to Joan J. Ryoo Joan J. Ryoo (= 1×) peers Stephen P. Kahanic

Countries citing papers authored by Joan J. Ryoo

Since Specialization
Citations

This map shows the geographic impact of Joan J. Ryoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan J. Ryoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan J. Ryoo more than expected).

Fields of papers citing papers by Joan J. Ryoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan J. Ryoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan J. Ryoo. The network helps show where Joan J. Ryoo may publish in the future.

Co-authorship network of co-authors of Joan J. Ryoo

This figure shows the co-authorship network connecting the top 25 collaborators of Joan J. Ryoo. A scholar is included among the top collaborators of Joan J. Ryoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan J. Ryoo. Joan J. Ryoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Patel, Jay, Vikram Attaluri, Joan J. Ryoo, et al.. (2023). Investigating Mortality Disparities Among Insured Patients With Colon Cancer Treated in an Integrated Health care System and Other Private Settings. The American Surgeon. 89(12). 5940–5948. 1 indexed citations
2.
3.
Ryoo, Joan J., et al.. (2020). Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer. Journal of the American College of Surgeons. 231(6). 681–692. 20 indexed citations
4.
Ryoo, Joan J., et al.. (2019). Prognostic Impact of Retropharyngeal Lymphadenopathy in HPV-associated Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 105(1). E412–E412. 1 indexed citations
5.
6.
Ryoo, Joan J., et al.. (2017). Radiotherapy for brain metastases near the end of life in an integrated health care system. Annals of Palliative Medicine. 6(S1). S28–S38. 14 indexed citations
7.
Ryoo, Joan J., et al.. (2015). Radiotherapy (RT) for brain metastases (BM) near the end of life (EOL): Palliation or poor-quality care?. Journal of Clinical Oncology. 33(29_suppl). 58–58. 1 indexed citations
8.
Ryoo, Joan J., Jennifer L. Malin, Diana L. Ordin, et al.. (2014). Facility Characteristics and Quality of Lung Cancer Care in an Integrated Health Care System. Journal of Thoracic Oncology. 9(4). 447–455. 13 indexed citations
9.
Oishi, Sabine, Anna Liza Antonio, Joan J. Ryoo, et al.. (2014). Quality of supportive care for patients with advanced lung cancer in the Veterans Health Administration. The Journal of Community and Supportive Oncology. 12(10). 361–369. 2 indexed citations
10.
Shelton, Jeremy B., Ted A. Skolarus, Diana L. Ordin, et al.. (2014). Validating electronic cancer quality measures at Veterans Health Administration.. PubMed. 20(12). 1041–7. 9 indexed citations
11.
Ryoo, Joan J., Diana L. Ordin, Anna Liza Antonio, et al.. (2013). Patient Preference and Contraindications in Measuring Quality of Care: What Do Administrative Data Miss?. Journal of Clinical Oncology. 31(21). 2716–2723. 28 indexed citations
12.
Kunitake, Hiroko, David S. Zingmond, Joan J. Ryoo, & Clifford Y. Ko. (2010). Caring for Octogenarian and Nonagenarian Patients with Colorectal Cancer: What Should Our Standards and Expectations Be?. Diseases of the Colon & Rectum. 53(5). 735–743. 69 indexed citations
13.
Ryoo, Joan J., Hiroko Kunitake, Stanley K. Frencher, et al.. (2009). Continuity of care: Readmission to the same hospital following gastric cancer resection. Journal of the American College of Surgeons. 209(3). S16–S17. 12 indexed citations
14.
Ryoo, Joan J. & Clifford Y. Ko. (2008). Minimizing Disparities in Surgical Care: A Research Focus for the Future. World Journal of Surgery. 32(4). 516–521. 3 indexed citations
15.
Krauss, Baruch, Aaron Deykin, Alexander Lam, et al.. (2005). Capnogram Shape in Obstructive Lung Disease. Anesthesia & Analgesia. 100(3). 884–888. 34 indexed citations
16.
Krauss, Baruch, Aaron Deykin, Alexander Lam, et al.. (2005). Capnogram Shape in Obstructive Lung Disease. Anesthesia & Analgesia. 1560–1560. 1 indexed citations
17.
Ryoo, Joan J., Craig E. Cole, & Kenneth C. Anderson. (2002). Novel therapies for multiple myeloma. Blood Reviews. 16(3). 167–174. 6 indexed citations
18.
Richardson, Paul G., Robert Schlossman, Edie Weller, et al.. (2002). Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma. Blood. 100(9). 3063–3067. 630 indexed citations breakdown →
19.
Richardson, PG, RL Schlossman, Teru Hideshima, et al.. (2001). A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM).. Blood. 98(11). 77516. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen P. Kahanic Breakdown of academic impact, for papers by Dorothy Romanus Breakdown of academic impact, for papers by Jianming He Breakdown of academic impact, for papers by Lucia Pantani Breakdown of academic impact, for papers by Christopher Enny Breakdown of academic impact, for papers by Stefanie Hieke Breakdown of academic impact, for papers by Jason Valent Breakdown of academic impact, for papers by A.K. Kakkar Breakdown of academic impact, for papers by Ming‐Chung Kuo Breakdown of academic impact, for papers by Claus Werenberg Marcher
Rankless by CCL
2026